Safety and Efficacy of CVI-LM001 in Patients With Hypercholesterolemia
Clinical trial NCT04438096 · UNKNOWN
Trial details
- NCT number
- NCT04438096
- Sponsor
- CVI Pharmaceuticals
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-15
- Primary completion
- 2021-12-15
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.